Literature DB >> 21227602

Correlates of risky injection practices among past-year injection drug users among the US general population.

Lauren R Ropelewski1, Brent E Mancha, Alicia Hulbert, Abby E Rudolph, Silvia S Martins.   

Abstract

BACKGROUND: With an estimated 1 million active injection drug users (IDUs), injection drug use continues to be a public health concern in the United States. Risky injection practices have been associated with the transmission of HIV, Hepatitis B and C, as well as other skin and soft tissue infections.
METHODS: We used data from 463 respondents, aged 18 and older, who were past-year IDUs in the 2005-2008 National Survey of Drug Use and Health (NSDUH). We investigated correlates of risky injection behavior among these recent IDUs.
RESULTS: Older age (≥ 35 versus 18-25) was associated with reusing one's own needle at last injection (aOR=1.80 [1.02-3.17], as were past year heroin (aOR=2.59 [1.18-5.66]) and cocaine injection (aOR=2.17 [1.13-4.15]). Past year crack cocaine use was positively associated with not cleaning needles with bleach (aOR=2.18 [1.10-4.33]). Past year cocaine injection was associated with obtaining needles in a risky manner (aOR=2.29 [1.23-4.25]). Methamphetamine injection was associated with obtaining needles in less risky ways (aOR=0.41 [0.20-0.84]).
CONCLUSION: Our findings indicate that some IDUs are continuing to engage in high risk injection behaviors. The identification of potential at-risk populations of IDUs may have implications for harm reduction interventions and HIV prevention programs.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21227602      PMCID: PMC3090520          DOI: 10.1016/j.drugalcdep.2010.11.025

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  45 in total

Review 1.  Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system.

Authors:  Kim M Blankenship; Amy B Smoyer; Sarah J Bray; Kristin Mattocks
Journal:  J Health Care Poor Underserved       Date:  2005-11

2.  Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study.

Authors:  Dezheng Huo; Lawrence J Ouellet
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

3.  Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland.

Authors:  Elizabeth T Golub; Joseph C Bareta; Shruti H Mehta; Lisa D McCall; David Vlahov; Steffanie A Strathdee
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

4.  Recruiting injection drug users: a three-site comparison of results and experiences with respondent-driven and targeted sampling procedures.

Authors:  William T Robinson; Jan M H Risser; Shanell McGoy; Adam B Becker; Hafeez Rehman; Mary Jefferson; Vivian Griffin; Marcia Wolverton; Stephanie Tortu
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

5.  Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

6.  HIV incidence among injection drug users in Baltimore, Maryland (1988-2004).

Authors:  Shruti H Mehta; Noya Galai; Jacquie Astemborski; David D Celentano; Steffanie A Strathdee; David Vlahov; Kenrad E Nelson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

7.  Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users.

Authors:  F Molitor; J D Ruiz; N Flynn; J N Mikanda; R K Sun; R Anderson
Journal:  Am J Drug Alcohol Abuse       Date:  1999-08       Impact factor: 3.829

8.  Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.

Authors:  Richard D Burt; Holly Hagan; Richard S Garfein; Keith Sabin; Cindy Weinbaum; Hanne Thiede
Journal:  J Urban Health       Date:  2007-05       Impact factor: 3.671

9.  Cocaine use and HIV risk behavior in methadone maintenance patients.

Authors:  D A Bux; R J Lamb; M Y Iguchi
Journal:  Drug Alcohol Depend       Date:  1995-01       Impact factor: 4.492

10.  Cocaine use and risky injection and sexual behaviors.

Authors:  R Hudgins; J McCusker; A Stoddard
Journal:  Drug Alcohol Depend       Date:  1995-01       Impact factor: 4.492

View more
  13 in total

1.  Circular migration by Mexican female sex workers who are injection drug users: implications for HIV in Mexican sending communities.

Authors:  Victoria D Ojeda; José Luis Burgos; Sarah P Hiller; Remedios Lozada; Gudelia Rangel; Alicia Vera; Irina Artamonova; Carlos Magis-Rodriguez
Journal:  J Immigr Minor Health       Date:  2012-02

2.  Differential risk factors for HIV drug and sex risk-taking among non-treatment-seeking hospitalized injection drug users.

Authors:  Denise Crooks; Judith Tsui; Bradley Anderson; Shernaz Dossabhoy; Debra Herman; Jane M Liebschutz; Michael D Stein
Journal:  AIDS Behav       Date:  2015-03

3.  Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego.

Authors:  Fátima Muñoz; José Luis Burgos; Jazmine Cuevas-Mota; Eyasu Teshale; Richard S Garfein
Journal:  AIDS Behav       Date:  2015-01

4.  Gender differences in planning ability and hepatitis C virus among people who inject drugs.

Authors:  J D Scheidell; M R Khan; L M Clifford; E M Dunne; L D Keen; W W Latimer
Journal:  Addict Behav       Date:  2015-03-26       Impact factor: 3.913

5.  The effects of oral d-amphetamine on impulsivity in smoked and intranasal cocaine users.

Authors:  Stephanie Collins Reed; Suzette M Evans
Journal:  Drug Alcohol Depend       Date:  2016-04-19       Impact factor: 4.492

6.  Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.

Authors:  Matthew J Akiyama; Daniel Lipsey; Moonseong Heo; Linda Agyemang; Brianna L Norton; Jennifer Hidalgo; Kiara Lora; Alain H Litwin
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

7.  Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study.

Authors:  Joshua A Barocas; Golnaz Eftekhari Yazdi; Alexandra Savinkina; Shayla Nolen; Caroline Savitzky; Jeffrey H Samet; Honora Englander; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

8.  Injecting drug use in Manipur and Nagaland, Northeast India: injecting and sexual risk behaviours across age groups.

Authors:  Gregory Armstrong; Amenla Nuken; Gajendra K Medhi; Jagadish Mahanta; Chumben Humtsoe; Melody Lalmuanpuaii; Michelle Kermode
Journal:  Harm Reduct J       Date:  2014-10-13

9.  Needle acquisition patterns, network risk and social capital among rural PWID in Puerto Rico.

Authors:  Ian Duncan; Patrick Habecker; Roberto Abadie; Ric Curtis; Bilal Khan; Kirk Dombrowski
Journal:  Harm Reduct J       Date:  2017-10-18

10.  Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs.

Authors:  Elizabeth Buckingham; Ezra Schrage; Francine Cournos
Journal:  Adv Prev Med       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.